Matinas BioPharma Holdings (MTNB) Long-Term Investments (2013 - 2025)
Matinas BioPharma Holdings (MTNB) posted quarterly Long-Term Investments of $70000.0 for Q3 2025, little changed quarter-over-quarter from $70000.0 in Q2 2025.
Matinas BioPharma Holdings (MTNB) Long-Term Investments (2013 - 2025) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Long-Term Investments for 6 consecutive years, with $70000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Long-Term Investments changed N/A year-over-year to $70000.0; the TTM figure through Sep 2025 stood at $70000.0 (changed N/A YoY), while the FY2017 annual figure was $535999.0, down 0.9% from the prior year.
- Long-Term Investments was little changed at $70000.0 in Q3 2025 per MTNB's latest filing, from $70000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $70000.0 in Q2 2025 and bottomed at $70000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Dec 31, 2017 | 535,999.00 |
| Sep 30, 2017 | 535,999.00 |
| Jun 30, 2017 | 536,001.00 |
| Mar 31, 2017 | 540,145.00 |
| Dec 31, 2016 | 540,845.00 |
| Sep 30, 2016 | 54,844.00 |
| Jun 30, 2016 | 54,844.00 |
| Mar 31, 2016 | 115,371.00 |
| Dec 31, 2015 | 115,370.00 |
| Sep 30, 2015 | 216,555.00 |
| Jun 30, 2015 | 216,475.00 |
| Mar 31, 2015 | 216,395.00 |
| Dec 31, 2014 | 216,317.00 |
| Sep 30, 2014 | 316,225.00 |
| Jun 30, 2014 | 316,105.00 |
| Mar 31, 2014 | 315,986.00 |
| Dec 31, 2013 | 315,778.00 |